IFIBYNE   05513
INSTITUTO DE FISIOLOGIA, BIOLOGIA MOLECULAR Y NEUROCIENCIAS
Unidad Ejecutora - UE
congresos y reuniones científicas
Título:
Alternative Splicing: multiple control mechanisms and involvement in human disease
Autor/es:
SREBROW ANABELLA
Lugar:
Buenos Aires
Reunión:
Simposio; Simposio Internacional "Genomics and pharmacogenomics of growth disorders".; 2011
Institución organizadora:
Serono Symposia International Foundation
Resumen:
<!--
/* Font Definitions */
@font-face
{font-family:Times;
panose-1:2 0 5 0 0 0 0 0 0 0;
mso-font-charset:0;
mso-generic-font-family:auto;
mso-font-pitch:variable;
mso-font-signature:3 0 0 0 1 0;}
@font-face
{font-family:Times;
panose-1:2 0 5 0 0 0 0 0 0 0;
mso-font-charset:0;
mso-generic-font-family:auto;
mso-font-pitch:variable;
mso-font-signature:3 0 0 0 1 0;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;
mso-font-charset:0;
mso-generic-font-family:auto;
mso-font-pitch:variable;
mso-font-signature:-520092929 1073786111 9 0 415 0;}
@font-face
{font-family:Cambria;
panose-1:2 4 5 3 5 4 6 3 2 4;
mso-font-charset:0;
mso-generic-font-family:auto;
mso-font-pitch:variable;
mso-font-signature:-536870145 1073743103 0 0 415 0;}
@font-face
{font-family:Palatino;
panose-1:2 0 5 0 0 0 0 0 0 0;
mso-font-charset:0;
mso-generic-font-family:auto;
mso-font-pitch:variable;
mso-font-signature:3 0 0 0 1 0;}
@font-face
{font-family:"MS Mincho";
mso-font-alt:"MS 明朝";
mso-font-charset:128;
mso-generic-font-family:modern;
mso-font-pitch:fixed;
mso-font-signature:-536870145 1791491579 18 0 131231 0;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{mso-style-unhide:no;
mso-style-qformat:yes;
mso-style-parent:"";
margin:0cm;
margin-bottom:.0001pt;
mso-pagination:widow-orphan;
font-size:12.0pt;
font-family:Cambria;
mso-fareast-font-family:"MS Mincho";
mso-bidi-font-family:"Times New Roman";}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
{mso-style-unhide:no;
mso-style-link:"Body Text Char";
margin:0cm;
margin-bottom:.0001pt;
text-align:justify;
text-justify:inter-ideograph;
mso-pagination:widow-orphan;
font-size:12.0pt;
mso-bidi-font-size:10.0pt;
font-family:Palatino;
mso-fareast-font-family:Times;
mso-bidi-font-family:"Times New Roman";
mso-no-proof:yes;}
span.BodyTextChar
{mso-style-name:"Body Text Char";
mso-style-unhide:no;
mso-style-locked:yes;
mso-style-link:"Body Text";
mso-ansi-font-size:12.0pt;
font-family:Palatino;
mso-ascii-font-family:Palatino;
mso-fareast-font-family:Times;
mso-hansi-font-family:Palatino;
mso-no-proof:yes;}
.MsoChpDefault
{mso-style-type:export-only;
mso-default-props:yes;
font-size:10.0pt;
mso-ansi-font-size:10.0pt;
mso-bidi-font-size:10.0pt;
font-family:Cambria;
mso-ascii-font-family:Cambria;
mso-fareast-font-family:"MS Mincho";
mso-hansi-font-family:Cambria;}
@page WordSection1
{size:595.0pt 842.0pt;
margin:72.0pt 90.0pt 72.0pt 90.0pt;
mso-header-margin:35.4pt;
mso-footer-margin:35.4pt;
mso-paper-source:0;}
div.WordSection1
{page:WordSection1;}
-->
Splicing is the process by
which introns are removed from the precursor messenger RNA (pre-mRNA) and
consecutive exons are joined, and constitutes a key step in the generation of mature
mRNA molecules ready for translation. This
process is carried out by the ?spliceosome?, a complex of small nuclear ribonucleoprotein
particles (snRNPs) and associated proteins that assemble on pre-mRNA in a
precise and stepwise manner, recognizing sequence-specific splice sites located
at the intron-exon boundaries.
Alternative splicing takes place when two or more
splice sites compete, allowing the differential removal of specific exonic
sequences from mature mRNA or inclusion of intronic ones, in a developmental
stage-, sex-, or tissue-specific manner. Alternative splicing represents an
extraordinary source of protein diversity as many different protein isoforms
that perform distinct and even antagonistic cellular activities can be
generated from a single pre-mRNA. Alternative splicing regulation is coupled to
transcription and is dependent on the interaction of splicing factors with cis-acting exonic or intronic motifs
termed splicing enhancers and splicing silencers. The activity of these factors
is modulated by post-translational modifications, in particular by
phosphorylation, which may also affect their cellular localization. Recent work
has begun to unravel the molecular mechanisms by which signal transduction
pathways activated by extracellular cues modulate the activity of these splicing
regulators and therefore the splicing pattern of different target pre-mRNAs.
Mutations that alter cis-acting splicing elements or
changes in the activity of splicing regulatory proteins that compromise the
accuracy of either constitutive or alternative splicing could have a profound
impact on human pathogenesis, in particular in tumour development and
progression. Therefore, the regulation of the splicing process is crucial to
assure the proper orchestration of cellular functions within multicellular
organisms.